Kadir Uludag | Educational Psychology | Educational Psychology Impact

Published on by Cognitive Scientist Awards

Dr. Kadir Uludag | Educational Psychology | Educational Psychology Impact

Dr. Kadir Uludag is a postdoctoral researcher in psychology with a Ph.D. in Applied Psychology from the University of Chinese Academy of Sciences. His research bridges schizophrenia, brain imaging, and educational psychology. Dr. Uludag is passionate about disseminating scientific knowledge through his personal website (ifx0.com/psychology), YouTube channel (youtube.com/boooringlearning), and as the founder of the open-access journal Novelty in Psychology. He has published extensively, including 12 Web of Science (Q1) and 21 Scopus-indexed works, and serves on the editorial boards of 24 international journals. With over 670 manuscript reviews listed on ORCID, he has received multiple awards recognizing his scientific contributions. Dr. Uludag also manages four ongoing book projects. Skilled in Python-based machine learning and data analysis tools, he is eager to collaborate on innovative research that contributes meaningfully to psychology and society.

Profile

Education šŸŽ“

Dr. Uludag earned his Ph.D. in Applied Psychology from the University of Chinese Academy of Sciences (2019ā€“2023, GPA 3.93), focusing on brain imaging and mental health. He completed an M.A. in Forensic Sciences (Social Sciences) from Istanbul University (2016ā€“2018, GPA 3.61), where he developed a strong foundation in psychological evaluation in legal settings. His undergraduate degree in Psychological Counseling and Guidance was obtained from Ƈanakkale Onsekiz Mart University (2012ā€“2016, GPA 3.30), complemented by an associate degree in Laboratory Assistant and Veterinary Sciences from Eskisehir Anatolian University (2013ā€“2015, GPA 3.79). He has also pursued training in TESOL, SPSS, machine learning (random forest, SVM, logistic regression, neural networks), Python programming, web development, and data visualization. His education has been guided by distinguished scholars including Prof. Xiang Yang Zhang, Prof. Erdinc Ozturk, and Prof. Neylan Ziyal. These experiences shaped his multidisciplinary approach to psychological research.

Experience šŸ‘Øā€šŸ«

Dr. Kadir Uludag is currently a postdoctoral researcher at Shanghai Jiao Tong University (2023ā€“Present) and has been appointed for a future role at Capital Medical University, Beijing (2025ā€“). His expertise spans schizophrenia, neuroimaging, and educational psychology. Previously, he served as a special education teacher for autistic children at KarabĆ¼k Municipality Autistic Children Education Center (2017), applying cognitive-behavioral and humanistic therapeutic approaches. He also completed internships as a psychological counselor at Toki Anadolu Lisesi (2016) and a veterinary technician at Safranbolu Veterinary Clinic (2015). He brings in-depth knowledge of psychological development and intervention techniques across diverse settings. In academia, Dr. Uludag serves on the editorial boards of 24 journals and has edited four book projects. His dynamic involvement in teaching, research, editing, and mentoring reflects a holistic commitment to the field of psychology and science communication.

Awards & Recognitions šŸ…

Dr. Uludag has received numerous accolades, including the ā€œHighest Number of Viewsā€ award (2023ā€“2024) from the Journal of Clinical and Basic Psychosomatics for his narrative review on smoking and schizophrenia. He earned reviewer awards from Imeta Journal and Imetaomics for reviewing more than five papers each. Additionally, he holds a Certificate of Excellence from the Shanghai Table Tennis Museum and the American Chemical Society Reviewer Lab Certificate. His extensive peer-review contributions (over 670 reviews) are recognized by ORCID and editorial teams worldwide. His editorial involvement includes serving on boards of journals like Health Policy and Technology, Plos One, and Asean Journal of Psychiatry, among others. He has received invitations for guest editorships and honorary memberships in various scholarly outlets. These honors reflect his impactful presence in academia and his dedication to advancing global psychological research.

Research Interests šŸ”¬

Dr. Kadir Uludagā€™s primary research interests include schizophrenia, neuroimaging (fMRI and EEG), and educational psychology. His doctoral work applied Python-based machine learning (random forest, SVM, logistic regression) to brain imaging data, emphasizing computational psychiatry and precision diagnostics. He has published in Q1 journals such as Asian Journal of Psychiatry, American Chemical Neuroscience, Psychology Research and Behavior Management, General Psychiatry, and Antioxidants. His Scopus-indexed contributions span educational psychology, forensic science, and neuroscience. His research applies interdisciplinary toolsā€”Python, Psychopy, SPSS, R, NLP, and image processing librariesā€”to explore psychiatric conditions. He integrates theory and practice through data visualization, cognitive-behavioral therapy models, and open-science advocacy. Dr. Uludag actively shares findings via his YouTube channel and academic website, fostering transparency and education. His work aims to bridge gaps between neuroscience, education, and technology to improve mental health outcomes and knowledge dissemination.

Publications

Faheem Arshad | Cognitive Neurosciences | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Faheem Arshad | Cognitive Neurosciences | Best Researcher Award

Dr. Faheem Arshad is an Assistant Professor of Neurology at the National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru. A leading cognitive neurologist in India, he specializes in dementia and neurodegenerative disorders. He played a pivotal role in establishing Indiaā€™s first cognitive disorders registry at NIMHANS, integrating clinical and research excellence. Dr. Arshad is a Senior Atlantic Fellow for Equity in Brain Health at the University of California, San Francisco (UCSF), and the first fellow from South Asia. His research integrates neurogenetics, biomarkers, imaging, and clinical trials, with a focus on inclusivity and low-literacy populations. He actively contributes to national and international collaborations and holds leadership roles within Indian and global neurology communities. Committed to early diagnosis, caregiver support, and prevention strategies, his work aims to improve brain health equity in diverse settings. His ongoing studies explore social interaction, bilingualism, and digital tools in dementia management.

Profile

Education šŸŽ“

Dr. Arshad received his foundational training in Internal Medicine (MD, 2014) at Sher-i-Kashmir Institute of Medical Sciences (SKIMS), Kashmir. He served as Registrar in Internal Medicine at AIIMS, New Delhi until 2016. He pursued advanced neurological training at the National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, earning a DM in Neurology (2019) and completing a Post-Doctoral Fellowship in Cognitive Neurosciences (2020). He furthered his expertise with a prestigious international fellowship in Global Brain Health Equity at the Global Brain Health Institute (GBHI), University of California, San Francisco (UCSF), USA in 2021. Dr. Arshad also holds the MRCP(UK) Neurology credential (2020), reflecting global competence. His multidisciplinary training spans cognitive neurology, imaging, biomarkers, and dementia prevention, equipping him with a holistic approach to brain health research and patient care.

Experience šŸ‘Øā€šŸ«

Dr. Faheem Arshadā€™s professional journey spans over a decade of clinical, academic, and research excellence. He is currently Assistant Professor of Neurology at NIMHANS, Bengaluru, where he has led initiatives in cognitive neurology since 2021. His early training included roles as Junior and Senior Resident in Internal Medicine at SKIMS and AIIMS, followed by Neurology Residency and Postdoctoral Fellowship at NIMHANS. He became a faculty leader and Convener of the Cognitive Neurology subsection of the Indian Academy of Neurology in 2023. Internationally, he served as an Atlantic Fellow at UCSFā€™s GBHI (2020ā€“2021), developing leadership in brain health equity. Dr. Arshad is a member of the American Academy of Neurology and other prestigious forums. He has published widely, initiated clinical trials, and built registries that bridge clinical insights with translational research. His work integrates social science, neurobiology, and global health in addressing dementia across underserved populations.

Awards & Recognitions šŸ…

Dr. Faheem Arshad has received numerous recognitions for his contributions to neurology and dementia research. He was awarded the Bursary Award at the TSS International Neuropsychiatry Conference (2018) for his work on social cognition in Frontotemporal Dementia. As the first South Asian to become a Senior Atlantic Fellow for Equity in Brain Health at UCSFā€™s GBHI, he has been globally recognized for championing equity in dementia care and research. His appointment as Convener of the Cognitive Neurology subsection by the Indian Academy of Neurology in 2023 highlights his leadership within the national academic community. He holds the MRCP(UK) in Neurology and is an active member of prestigious societies, including the American Academy of Neurology. These honors reflect his ongoing commitment to research innovation, community-based care models, and international collaboration in the field of neurodegenerative disorders.

Research Interests šŸ”¬

Dr. Faheem Arshadā€™s research focuses on dementia, particularly Frontotemporal Dementia (FTD), Alzheimerā€™s Disease, and related neurodegenerative conditions. He investigates cognitive reserve, biomarkers, social cognition, neuroimaging, and bilingualism in dementia resilience. His landmark projects include exploring the role of social interaction in FTD (GBHI-AA), plasmapheresis in Alzheimerā€™s (ICMR), cognitive testing in low-literacy settings, and bilingualismā€™s impact on cognitive reserve (NIH-funded). He co-leads a SERB-funded project using speech features for early dementia detection and a DBT-funded imaging study for vascular dementia diagnosis. He established Indiaā€™s first cognitive disorders registry at NIMHANS, integrating socio-demographics, imaging, and biomarker data. His work bridges clinical neurology and public health, emphasizing inclusive research for underrepresented populations. A strong advocate for clinical trials in LMICs, his studies integrate AI tools, cross-cultural data, and longitudinal analyses to improve early diagnosis and therapeutic strategies in dementia care.

Publications

Lucas MuƱoz-Lopez | Neuroscience | Best Academic Researcher Award

Published on by Cognitive Scientist Awards

Dr. Lucas MuƱoz-Lopez | Neuroscience | Best Academic Researcher Award

El Dr. Lucas MuƱoz-LĆ³pez šŸŽ“ es logopeda neurolĆ³gico especializado en rehabilitaciĆ³n logopĆ©dica en daƱo neurolĆ³gico šŸ§ , con amplia experiencia clĆ­nica y acadĆ©mica šŸ‘Øā€šŸ«. Tras graduarse en Logopedia por la Universidad de Granada en 2015, combinĆ³ prĆ”ctica profesional y formaciĆ³n de posgrado, incluyendo dos mĆ”steres y un doctorado con menciĆ³n Cum Laude šŸ…. Ha ejercido como docente universitario en Melilla y Ceuta, y colabora en investigaciĆ³n con publicaciones en revistas como Frontiers in Psychology šŸ“–. AdemĆ”s, ha tutorizado numerosos TFG y TFM šŸŽ“. Su trabajo integra logopedia clĆ­nica, investigaciĆ³n sobre alteraciones de la comunicaciĆ³n y neurociencias, aportando al avance acadĆ©mico y a la rehabilitaciĆ³n de pacientes. Es autor de un libro publicado y miembro activo en proyectos de evaluaciĆ³n y tratamiento en contextos educativos y sanitarios šŸ„. Su pasiĆ³n por la docencia y la terapia lo posiciona como referente en logopedia clĆ­nica e investigaciĆ³n šŸ“ˆ.

Profile

Education šŸŽ“

Dr. MuƱoz-LĆ³pez šŸ§  iniciĆ³ su carrera acadĆ©mica con el Grado en Logopedia (2015) en la Universidad de Granada šŸŽ“, complementĆ”ndolo ese mismo aƱo con un MĆ”ster en Logopedia ClĆ­nica en DaƱo Cerebral (Isep Clinic, Madrid) šŸ’”. En 2017 completĆ³ su segundo mĆ”ster en Neurociencias BĆ”sicas y Aplicadas y Dolor en la Facultad de Medicina de Granada šŸ”¬. CulminĆ³ su formaciĆ³n con un Doctorado en PsicologĆ­a y Logopedia en la Universidad de Granada (2021) con menciĆ³n Cum Laude šŸ…, convirtiĆ©ndose en experto en alteraciones de la comunicaciĆ³n y rehabilitaciĆ³n neurolĆ³gica šŸ§¬. Su formaciĆ³n acadĆ©mica combina sĆ³lidos conocimientos clĆ­nicos, teĆ³ricos y metodolĆ³gicos para abordar con Ć©xito la intervenciĆ³n logopĆ©dica y la investigaciĆ³n cientĆ­fica šŸ›ļø. AdemĆ”s, su trabajo refleja una constante actualizaciĆ³n y compromiso con la excelencia educativa y terapĆ©utica šŸ’Æ.

Experience šŸ‘Øā€šŸ«

Desde 2015, el Dr. MuƱoz-LĆ³pez šŸ©ŗ ha desarrollado una sĆ³lida trayectoria profesional como logopeda clĆ­nico, combinando prĆ”ctica asistencial con docencia universitaria šŸ‘Øā€šŸ«. Ha ejercido en el Centro de ValoraciĆ³n y OrientaciĆ³n de Granada como Auxiliar TĆ©cnico en Logopedia šŸ„, ademĆ”s de impartir clases en los campus de Ceuta y Melilla de la Universidad de Granada šŸ“š. Ha sido tutor de TFG y TFM en varias universidades, incluyendo la Universidad de Granada y la Universidad Internacional de La Rioja āœļø. Su experiencia docente abarca asignaturas de logopedia, neuropsicologĆ­a y psicopedagogĆ­a en grados y mĆ”steres universitarios šŸŽ“. AdemĆ”s, colabora activamente en proyectos de intervenciĆ³n educativa, rehabilitaciĆ³n y formaciĆ³n de futuros profesionales. Su enfoque multidisciplinar y experiencia en contextos clĆ­nicos y penitenciarios šŸ›ļø le permiten aplicar soluciones eficaces e innovadoras en su Ć”rea.

Awards & Recognitions šŸ…

Dr. MuƱoz-LĆ³pez ha recibido menciĆ³n Cum Laude šŸŽ–ļø por su tesis doctoral en PsicologĆ­a y Logopedia en la Universidad de Granada (2021) šŸ…. Su tesis fue publicada como libro šŸ“—, reafirmando su valor acadĆ©mico. Ha logrado publicar en la revista Frontiers in Psychology (Q2, JCR 2.99) šŸ§ , destacĆ”ndose en el Ć”rea de psicologĆ­a y neurociencias. TambiĆ©n ha publicado en la revista Journal for Educators, Teachers and Trainers, indexada en bases relevantes como Scopus y Dialnet šŸ“–. Su libro fue editado por la Editorial AcadĆ©mica EspaƱola, con Ć­ndice ICEE de 0.299 šŸ“˜. Estos reconocimientos consolidan su reputaciĆ³n cientĆ­fica, reflejando la calidad y relevancia de su producciĆ³n acadĆ©mica, asĆ­ como su compromiso con la excelencia investigadora y docente šŸ§‘ā€šŸ”¬āœØ.

Research Interests šŸ”¬

El Dr. MuƱoz-LĆ³pez centra su investigaciĆ³n en la rehabilitaciĆ³n logopĆ©dica de alteraciones de la comunicaciĆ³n šŸ—£ļø, disfagia šŸ„„ y terapia miofuncional šŸ’Ŗ, con especial atenciĆ³n a contextos neurolĆ³gicos y penitenciarios šŸ›ļø. Su trabajo profundiza en la intersecciĆ³n entre neurociencias, psicologĆ­a y logopedia šŸ§ , explorando tanto enfoques clĆ­nicos como educativos. Ha contribuido al avance del conocimiento en alteraciones del lenguaje, evaluaciĆ³n cognitiva y tĆ©cnicas de intervenciĆ³n para pacientes con daƱo cerebral adquirido šŸ§¬. AdemĆ”s, participa en estudios sobre integraciĆ³n social, intervenciĆ³n educativa en contextos de riesgo y psicologĆ­a forense āš–ļø. Su enfoque combina metodologĆ­a cuantitativa, intervenciĆ³n basada en evidencia y aplicaciĆ³n clĆ­nica, orientado siempre a mejorar la calidad de vida de las personas con trastornos de la comunicaciĆ³n šŸ’¬šŸ’”.

Publications

  • Validation and Spanish Adaptation of the Resilience Scale ER-23 in a University Population

    Healthcare
    2025-04-12 |Ā Journal article
    DOI:Ā 10.3390/healthcare13080886
    CONTRIBUTORS: Isabel RamĆ­rez-UclĆ©s; Julia Otero; F. Pablo Holgado-Tello; Lucas MuƱoz-LĆ³pez; MarĆ­a B. SĆ”nchez-Barrer

  • Analysis of writing in personality disorders in prison population

    Frontiers in Psychiatry
    2024 |Ā Journal article
    DOI:Ā 10.3389/fpsyt.2024.1391463
    EID:
    Part ofISSN:Ā 16640640
    CONTRIBUTORS:Ā MuƱoz-LĆ³pez, L.;Ā FernĆ”ndez-GarcĆ­a-Valdecasas, B.;Ā LĆ³pez-RodrĆ­guez, S.;Ā SĆ”nchez-Barrera, M.B.

  • Transformation of Higher Education: Discussion of the Dimensions, Trends and Scenarios of Change in Ibero-America

    Education Sciences
    2024 |Ā Journal article
    DOI:Ā 10.3390/educsci14050523
    Part ofISSN:Ā 22277102
    CONTRIBUTORS: FernĆ”ndez Cruz, M.; FernĆ”ndez GarcĆ­a Valdecasas, B.; MuƱoz LĆ³pez, L.; LĆ³pez RodrĆ­guez, S

  • Associations of Reversal Learning Performance With Personality Disorder Profile and Drug Abuse History in a Sample of Prison Inmates

    2024-09-18 |Ā Journal article
    DOI:Ā 10.1177/10731911241278307
    CONTRIBUTORS: Raquel MartĆ­n-RĆ­os; JosĆ© C. Perales; Francisca LĆ³pez-Torrecillas; Lucas MuƱoz LĆ³p

Jolanta Dorszewska | Neurobiology | Women Researcher Award

Published on by Cognitive Scientist Awards

Dr. Jolanta Dorszewska | Neurobiology | Women Researcher Award

Professor Jolanta Dorszewska is a globally recognized neuroscientist and pharmacologist based at Poznan University of Medical Sciences, Poland šŸ§ šŸ‡µšŸ‡±. She leads the Laboratory of Neurobiology, exploring the molecular and genetic basis of neurodegenerative diseases šŸ§¬. With over 35 years of academic experience, her work spans neurochemistry, clinical neurology, and genetic research in Alzheimerā€™s and Parkinsonā€™s disease šŸ§Ŗ. A prolific author, she has contributed to 80+ research papers, 50+ reviews, and 30+ book chapters šŸ“š. She serves on editorial boards of top neuroscience journals and holds leadership roles in national and international neurological societies šŸŒ.

Profile

Education šŸŽ“

Prof. Dorszewska earned her M.Sc. in Pharmacy with distinction from Poznan University of Medical Sciences in 1987 šŸ…. She completed board certifications in Pharmaceutical Analytics (1990 & 1997) and received her Ph.D. in 1996 šŸ§Ŗ. In 2004, she qualified as an Associate Professor and achieved full Professorship in 2016 šŸŽ“. Her academic growth includes training in medical genetics from 2012 to 2020 šŸ§¬. Her education reflects an evolving blend of pharmacy, neurobiology, and genetics, forming the foundation of her current research excellence šŸ’”.

Experience šŸ‘Øā€šŸ«

Prof. Dorszewska began as an Assistant in the Dept. of Pharmacy (1987-88), then in Clinical Neurochemistry (1988-96) at PUMS šŸ‘©ā€šŸ”¬. She was a Research Scientist in New York (1999ā€“2000) šŸ—½ and has led the Laboratory of Neurobiology since 2004 šŸ§ . She became Full Professor in 2022 šŸ›ļø. She also lectured at the National High Medical School in Pila (2012ā€“2018) šŸ“–. Her career blends hands-on research, global collaboration, and dedicated academic leadership šŸ“š. She continues to mentor, publish, and drive innovations in neurology and neurochemistry šŸš€

Awards & Recognitions šŸ…

Awards and Honors:
Prof. Dorszewska is a Local Honorary Member of the 12th World Congress on Controversies in Neurology (2018) šŸŒ. She has served as Guest Editor for 6 prestigious theme issues and holds editorial roles in top-tier journals like Frontiers in Molecular Neuroscience and Current Alzheimer Research šŸ“˜. A section and associate editor for journals across the USA, UK, and Poland šŸŒ, sheā€™s a key figure in scientific publishing šŸ–‹ļø. Sheā€™s affiliated with the Polish Academy of Sciences and international neurological societies and has co-edited 5 books šŸ“š.

Research Interests šŸ”¬

Research Focus:
Her research spans lipid metabolism in hypoxia šŸ§«, cerebral sterols šŸ§ , neurotransmitters (serotonin, dopamine) šŸ§Ŗ, apoptosis in aging and disease (Alzheimerā€™s, Parkinsonā€™s) šŸ’”, and gene polymorphisms (MTHFR, MAO-B, PARK) šŸ§¬. She investigates homocysteine metabolism, catecholamine pathways, and molecular changes in neurodegeneration šŸ§ . Since 2009, sheā€™s focused on genetic mutations (PARK, APOE), biomarkers (ASN, microRNAs), and migraine genetics āš™ļø. She uses advanced techniques like HPLC, PCR, ELISA, and immunohistochemistry šŸ”. Her interdisciplinary work integrates neurobiology, pharmacogenomics, and molecular neuroscience in tackling brain diseases šŸš€.

PublicationsĀ 

  • Genetic variants of ZNF746 and the level of plasma Parkin, PINK1, and ZNF746 proteins in patients with Parkinson’s disease

    IBRO Neuroscience Reports
    2025-06 |Ā Journal article
    DOI:Ā 10.1016/j.ibneur.2025.01.016
    CONTRIBUTORS:Ā Jolanta Dorszewska;Ā Jolanta Florczak-Wyspiańska;Ā Bartosz Słowikowski;Ā Wojciech Owecki;Ā Oliwia Szymanowicz;Ā Ulyana Goutor;Ā Mateusz Dezor;Ā Paweł P. Jagodziński;Ā Wojciech Kozubski

  • Kinesiotherapeutic Possibilities and Molecular Parameters in Multiple Sclerosis

    Sclerosis
    2025-04-03 |Ā Journal article
    DOI:Ā 10.3390/sclerosis3020013
    CONTRIBUTORS: Katarzyna Wiszniewska; Małgorzata Wilk; Małgorzata Wiszniewska; Joanna Poszwa; Oliwia Szymanowicz; Wojciech Kozubski; Jolanta Dorszewsk

  • Unraveling the Role of Proteinopathies in Parasitic Infections

    Biomedicines
    2025-03-03 |Ā Journal article
    DOI:Ā 10.3390/biomedicines13030610
    CONTRIBUTORS:Ā Mikołaj Hurła;Ā Damian Pikor;Ā Natalia Banaszek-Hurła;Ā Alicja Drelichowska;Ā Jolanta Dorszewska;Ā Wojciech Kozubski;Ā Elżbieta Kacprzak;Ā Małgorzata Paul

  • Expression of Neuronal Nicotinic Acetylcholine Receptor and Early Oxidative DNA Damage in Aging Rat Brainā€”The Effects of Memantine

    International Journal of Molecular Sciences
    2025-02-14 |Ā Journal article
    DOI:Ā 10.3390/ijms26041634
    CONTRIBUTORS:Ā Małgorzata Anna Lewandowska;Ā Agata RĆ³Å¼ycka;Ā Teresa Grzelak;Ā Bartosz Kempisty;Ā Paweł Piotr Jagodziński;Ā Margarita Lianeri;Ā Jolanta Dorszewska

LUCIANO VITORINO | Cognitive Aging | Cognitive Aging Excellence

Published on by Cognitive Scientist Awards

Dr. LUCIANO VITORINO | Cognitive Aging | Cognitive Aging Excellence

Dr. Luciano MagalhĆ£es Vitorino, Ph.D., RN šŸ‡§šŸ‡· is a dedicated professor at the Faculty of Medicine of ItajubĆ”, Brazil šŸ„, with expertise in nursing, gerontology, spirituality, and health šŸŒ±. He has built a multidisciplinary academic and research career blending healthcare, cognition, and spirituality šŸ§ šŸ™. With over 1,500 citations šŸ“š and extensive teaching roles in medicine and nursing šŸ©ŗ, he leads the Research Center and the Assessment Center at FMIT, actively contributing to the Research Ethics Committee šŸ‘Øā€šŸ”¬. His international academic collaborations, including the University of Alberta šŸ‡ØšŸ‡¦, reflect his global engagement šŸŒ. A recognized academic voice, he served as Guest Editor for Frontiers in Psychiatry šŸ“° and holds memberships across academic platforms šŸ“Š. Through education, mentorship, and pioneering research, Dr. Luciano is influencing healthcare for the aging population šŸ’”šŸ‘“šŸ‘µ.

Profile

Education šŸŽ“

Dr. Luciano holds a Postdoctoral Fellowship in Cognition, Spirituality, and Aging from UFJF (2017ā€“2019) šŸ§˜ā€ā™‚ļøšŸ§ , a Ph.D. and M.Sc. in Quality of Life & Spiritual Health from UNIFESP (2012ā€“2016) šŸ“–, and a B.Sc. in Nursing from Faculty of Nursing Wenceslau Braz (2006) šŸ©ŗ. He specialized in Urgency and Emergency Care (2008ā€“2010) ā›‘ļø. His Ph.D. work was guided by experts from UNIFESP and the University of Alberta šŸ‡ØšŸ‡¦, exploring spiritual/religious coping among older adults. His dissertation and thesis focused on quality of life and religious coping in nursing homes and community settings šŸ™šŸ˜ļø. His postdoctoral project assessed spirituality’s influence on cognitive decline in aging populations šŸ§“. This unique education, combining nursing, public health, and spirituality, positions him as a thought leader in holistic geriatric care

Experience šŸ‘Øā€šŸ«

Dr. Luciano is a full-time assistant professor at FMIT since 2018 šŸ‘Øā€šŸ«. He coordinates both the Research Center (since 2022) and Assessment Center (since 2022), and is a long-standing member of the Research Ethics Committee (since 2019) šŸ§ŖšŸ“‹. He previously taught at Faculty of Nursing Wenceslau Braz (2007ā€“2012), Medical School of ItajubĆ” (2013ā€“2014), and Federal University of SĆ£o Paulo (2013) šŸ‘Øā€āš•ļøšŸ“˜. Heā€™s also guided health residency programs and coordinated caregiver training for elderly individuals šŸ‘µšŸ‘Øā€āš•ļø. As Guest Editor of Frontiers in Psychiatry (2022ā€“2023), he shaped international discussions on spirituality and health šŸ—žļøšŸ•Šļø. His teaching subjects include Epidemiology, Geriatrics, Medical Semiology, and Spirituality & Health šŸ§¬šŸ©». His roles reflect a passion for interdisciplinary health sciences and dedication to ethical, evidence-based care šŸŒŸ.

Awards & Recognitions šŸ…

Dr. Lucianoā€™s impactful research and teaching have earned him numerous citations across Scopus (h-index 13, 525 citations), Web of Science (h-index 11, 454 citations), Google Scholar (h-index 20, 1,506 citations) šŸ“ˆ, and ResearchGate (h-index 16, 864 citations) šŸ§‘ā€šŸ”¬. His inclusion as Guest Editor for Frontiers in Psychiatry (2022ā€“2023) showcases recognition in global academic communities šŸŒ. Heā€™s contributed to leading Brazilian and international institutions like UNIFESP, UFJF, and the University of Alberta šŸ‡§šŸ‡·šŸ‡ØšŸ‡¦. Through strong publication records and global collaborations, heā€™s established himself as an authority on spiritual health in aging šŸš€šŸ“š. His profile on Google Scholar, ORCID, and LinkedIn reflects international engagement and scholarly distinction šŸŒšŸŽ–ļø.

Research Interests šŸ”¬

Dr. Lucianoā€™s research bridges Geriatrics, Gerontology, Spirituality and Mental Health, and AI in Healthcare šŸ§“šŸ§ šŸ’». His central interest lies in understanding how spirituality and religiosity affect cognitive aging and quality of life šŸŒæšŸ§˜ā€ā™‚ļø. His postdoctoral researchā€”a 4-year longitudinal studyā€”explored how spiritual coping impacts cognitive decline in community-dwelling elders šŸ§ŖšŸ•Æļø. He also investigates medical education, primary healthcare, and interdisciplinary training šŸ©ŗšŸ“˜. As AI transforms healthcare, he examines its integration with geriatric care and spiritual health frameworks šŸ¤–ā¤ļø. Through mixed-methods research and international collaboration, he aims to personalize elderly care and mental wellness using both humanistic and data-driven approaches šŸ“ŠāœØ.

PublicationsĀ 

Gerd Fabian Volk | Cognitive Rehabilitation | Outstanding Scientist Award

Published on by Cognitive Scientist Awards

Dr. Gerd Fabian Volk | Cognitive Rehabilitation | Outstanding Scientist Award

apl. Prof. Dr. med. habil. Gerd Fabian Volk (šŸ‘¶1978, Wertheim am Main) is a leading German otolaryngologist šŸ‘Øā€āš•ļø, currently serving as Senior Physician and Head of the Facial Nerve Center in Jena šŸ„. With a deep commitment to clinical excellence, academic teaching šŸ“š, and innovative research šŸ§Ŗ, he has significantly contributed to the fields of neurolaryngology, facial nerve disorders, and ultrasound diagnostics šŸ§ šŸ—£ļø. His work bridges cutting-edge imaging šŸ–¼ļø and functional diagnostics for head-neck disorders. Living in Jena with his family šŸ‘Øā€šŸ‘©ā€šŸ‘§ā€šŸ‘§, he actively supports patient education through YouTube šŸ“¹, coordinates national workshops, and advocates for interdisciplinary collaboration šŸ¤. Volk is a respected speaker šŸŽ¤, faculty member at international dissection courses āœ‚ļøšŸ§ , and an initiator of hybrid symposia. He balances leadership with education, translating research into real-world clinical impact šŸŒšŸ’”.

Profile

Education šŸŽ“

Studied human medicine at WestfƤlische Wilhelms UniversitƤt MĆ¼nster (1999ā€“2006) šŸŽ“šŸ©ŗ, earning his state exam. In 2007, he completed his doctorate (Dr. med.) with a thesis on axonal regeneration in retinal ganglion cells in primates and rats šŸ§¬šŸ’šŸ€. He achieved board certification in ENT (2012) šŸ‘‚šŸ‘ƒšŸ§  and earned his postdoctoral qualification (habilitation) in 2017 with pioneering research on quantitative imaging of facial muscles šŸ–¼ļøšŸ’Ŗ. His venia legendi was granted by Friedrich Schiller University Jena in otorhinolaryngology šŸ“œšŸ‘Øā€šŸ«. Further qualifications include DEGUM Level II (2018) for ultrasound, clinical trial leadership certification (2009), animal research leadership certification (2002), and interdisciplinary leadership training at UKJ šŸ…šŸ“Š. His broad educational background underpins his medical, scientific, and didactic work, combining clinical care, diagnostics, and teaching for the next generation of ENT specialists šŸ‘Øā€āš•ļøšŸ‘©ā€āš•ļøšŸ‘Øā€šŸ«.

Experience šŸ‘Øā€šŸ«

Since 2013, Dr. Volk leads the Facial Nerve Center in Jena and co-founded the Tinnitus Center šŸ‘Øā€āš•ļøšŸ”Š. He is currently Senior Physician at the ENT Department, University Hospital Jena and member of the steering committee for the Center for Rare Diseases Jena (since 2024) šŸ§©šŸ§¬. He previously held rotational research fellowships in radiology and neurology (2008ā€“2013) and has organized national ENT courses since 2009 šŸ§ šŸŽ“. With consistent academic teaching since 2012, he has led cadaver dissection courses, neurolaryngology workshops, and ultrasound diagnostics trainings šŸ§‘ā€šŸ«šŸ’». He is an active contributor to ethics commissions and rare disease networks šŸ‘„āš–ļø. His work merges clinical ENT practice, surgical skill, and educational outreach through digital platforms (e.g., YouTube, www.lemg.org) šŸŒšŸ“¹. A devoted mentor, he organizes monthly PhD symposia and integrates hybrid teaching formats, balancing high-level medical care with forward-thinking academic initiatives šŸ“ššŸ„šŸŽÆ.

Awards & Recognitions šŸ…

Recipient of multiple national prizes, including the 1st Poster Prize by the German Society for Ultrasound in Medicine (2019) šŸ„‡šŸ“Š for Parkinson-related facial muscle imaging, and the DEGUM Head-Neck Section Award for his habilitation research (2018) šŸ§ šŸ…. Awarded competitive IZKF research fellowships in neurology and radiology (2008ā€“2013) šŸ§¬šŸ”¬. Recognized leader in rare disease diagnostics and member of Germanyā€™s CRANIO-Net for rare craniofacial disorders (since 2022) šŸ§©šŸ‘¶. Since 2020, he contributes to the Ethics Commission of the University Hospital Jena āš–ļø. He is speaker for ENT indications in the Botulinumtoxin Working Group of the German Society of Neurology (since 2022) šŸ’‰šŸ§ . Nominated for professorial posts in Bielefeld, Halle, and CharitĆ© Berlin between 2019ā€“2023 šŸ›ļøšŸ“š. Volkā€™s sustained excellence across clinical care, diagnostics, research, and education has earned him national recognition and leadership roles in academic ENT medicine šŸ§ šŸ„āœØ.

Research Interests šŸ”¬

Prof. Volk’s research centers on facial nerve diagnostics and therapy šŸ§ šŸ§‘ā€āš•ļø, neurolaryngology, and ultrasound imaging of head-neck structures šŸ–¼ļø. He specializes in quantitative imaging of facial muscles for conditions like facial paralysis and Parkinsonā€™s disease šŸ¤–šŸ§ . His work combines clinical neurophysiology, MRI analysis, and laryngeal electromyography (LEMG) šŸ“ˆšŸ’¬. He also pioneers educational innovations in hybrid learning, simulation-based teaching, and cadaver dissection techniques for ENT and neurology professionals šŸ§‘ā€šŸ«šŸ§Ŗ. Through platforms like www.lemg.org and dedicated YouTube channels šŸ“¹, he disseminates knowledge on advanced diagnostics such as salivary duct endoscopy, voice disorders, and botulinum toxin use šŸ’‰. A strong advocate for interdisciplinary networks and rare disease research, he leads initiatives in patient-centered care, including organizing the ā€œFazialis-Nerv-Tagā€ and supporting patient education šŸ¤ā¤ļø. His translational research aims to enhance diagnostic precision and develop novel rehabilitation strategies for complex craniofacial disorders šŸ§¬šŸ”§.

PublicationsĀ 

  • Electromyography as an Objective Outcome Measure for the Therapeutic Effect of Biofeedback Training to Reduce Post-Paralytic Facial Synkinesis

    Healthcare
    2025-03-04 |Ā Journal article
    DOI:Ā 10.3390/healthcare13050550
    CONTRIBUTORS:Ā Isabell Hahnemann;Ā Julia Fron;Ā Jonas Ballmaier;Ā Orlando Guntinas-Lichius;Ā Gerd Fabian Volk

  • Evaluation of the Effects of an Electromyography-Based Bio-Feedback Training of Patients with Post-Paralytic Facial Synkinesis Using Electromyography Amplitudes as Objective Outcome Measure

    2024-12-16 |Ā Preprint
    DOI:Ā 10.20944/preprints202412.1326.v1
    CONTRIBUTORS:Ā Isabell Hahnemann;Ā Julia Fron;Ā Jonas Ballmaier;Ā Orlando Guntinas-Lichius;Ā Gerd Fabian Volk

  • Deceleration of denervated facial muscle atrophy through functional electrical stimulation: a sonographic quantification in patients with facial nerve paralysis

    European Journal of Translational Myology
    2024-11-13 |Ā Journal article
    DOI:Ā 10.4081/ejtm.2024.13162
    CONTRIBUTORS:Ā Gabriel Meincke;Ā Johannes KrauƟ;Ā Maren Geitner;Ā Anna-Maria Kuttenreich;Ā Dirk Arnold;Ā Jonas Ballmaier;Ā Thomas Lehmann;Ā Winfried Mayr;Ā Orlando Guntinas-Lichius;Ā Gerd Fabian Volk

Elsa Pittaras | Neuroscience | Women Researcher Award

Published on by Cognitive Scientist Awards

Dr. Elsa Pittaras | Neuroscience | Women Researcher Award

Elsa Pittaras is a Basic Life Research Scientist at Stanford University, specializing in neuroscience, cognition, and sleep research. With expertise in molecular biology, neuroanatomy, pharmacology, and behavior, she has extensively studied decision-making processes in mice. Her research has contributed significantly to understanding sleep deprivation’s effects on cognition and memory in Down Syndrome and Alzheimer’s disease models. She has published multiple papers as both first and last author, showcasing her leadership in neuroscience. Elsa’s goal is to advance research on mood disorders, cognition, and neurochemistry, aspiring to become an independent researcher in the U.S. šŸ‡ŗšŸ‡øšŸ”¬šŸ§ 

Profile

Education šŸŽ“

Elsa Pittaras earned a B.S. in Physiology from the University of Caen (2010), an M.S. in Neuroscience from the University of Paris Sud and ENS Cachan (2012), and a Ph.D. in Neuroscience from Neuro-PSI and the Biomedical Research Unit of the French Army (2016). Her multidisciplinary foundation in biology, physics, chemistry, and mathematics from ChĆ¢telet, Douai (2009) laid the groundwork for her neuroscience expertise. Throughout her education, she focused on decision-making, sleep deprivation, and neurochemical mechanisms in cognition. šŸ§ šŸ“ššŸŽ“

Experience šŸ‘Øā€šŸ«

Elsa Pittaras has been a Basic Life Research Scientist at Stanford University since 2022, focusing on cognitive enhancement in Down Syndrome and Alzheimerā€™s disease models. She was a Postdoctoral Fellow at Stanford (2017-2022), investigating sleep and circadian rhythmsā€™ effects on memory. Previously, she conducted research at the Biomedical Research Unit of the French Army (2016-2017) and completed her Ph.D. at Neuro-PSI. Her career includes internships in neuroscience at Neuro-PSI (2011-2012) and clinical observations at CHU Caen (2010). šŸ›ļøšŸ§¬šŸ§Ŗ

Research Interests šŸ”¬

Elsaā€™s research explores decision-making, memory, and sleep in neurodevelopmental disorders. She pioneered the Mouse Gambling Task, revealing individual decision-making strategies. Her Ph.D. identified neurochemical markers of decision-making behaviors and the effects of sleep deprivation. At Stanford, she investigates sleepā€™s impact on cognition in Down Syndrome and Alzheimerā€™s models, aiming to improve memory and sleep quality through pharmacological interventions. Her work bridges behavioral neuroscience with neurochemistry to enhance cognitive function. šŸ§ šŸ’”šŸ›Œ

Awards & Recognitions šŸ…

Elsa has received prestigious grants, including the Jerome Lejeune Research Grants (2019, 2020), the Fyssen Foundation Research Grant (2017), and travel awards for conferences such as T21RS (2021) and Advances in Sleep and Circadian Science (2019). She was also recognized by the French Society for Research and Sleep Medicine (2014) and received a European Neuroscience Federation travel award (2016). šŸ…

PublicationsĀ 

  • Selectively Blocking Small Conductance Ca2+-Activated K+ Channels Improves Cognition in Aged Mice.

  • Short-term Ī³-aminobutyric acid antagonist treatment improves long-term sleep quality, memory, and decision-making in a Down syndrome mouse model

  • Behavioral and Neuronal Characterizations, across Ages, of the TgSwDI Mouse Model of Alzheimer’s Disease.

  • Inter-individual differences in cognitive tasks: focusing on the shaping of decision-making strategies

  • Handling, task complexity, time-of-day, and sleep deprivation as dynamic modulators of recognition memory in mice

  • Enhancing sleep after training improves memory in down syndrome model mice

 

Aynur MĆ¼dĆ¼roğlu Kırmızıbekmez | Neurodevelopmental Disorders | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof Dr. Aynur MĆ¼dĆ¼roğlu Kırmızıbekmez | Neurodevelopmental Disorders | Best Researcher Award

Asst. Prof. Aynur MĆ¼dĆ¼roğlu Kırmızıbekmez is a neuroscientist at Ä°stanbul Nişantaşı University, specializing in neurodegenerative diseases, neuroprotection, and the gut-brain axis. She completed her Ph.D. in Neuroscience at Istanbul University in 2013 and has been a faculty member since 2014. Her research spans Alzheimer’s, autism, and Parkinsonā€™s disease, focusing on stem cell therapies and functional foods for cognitive enhancement. She has led TƜSEB-approved projects and holds patents on bioactive functional foods. Aynur teaches Neurology, Cognitive Neurophysiology, and Industrial Biotechnology. She actively contributes to cutting-edge innovations, particularly in prebiotic-microbiota interactions.

Profile

Education šŸŽ“

Aynur MĆ¼dĆ¼roğlu Kırmızıbekmez earned her Ph.D. in Neuroscience from Istanbul University in 2013. Her academic journey emphasized neurobiology, neurodegenerative disease mechanisms, and innovative therapeutic strategies. Her doctoral research focused on neuroprotective compounds in Alzheimerā€™s disease. Before her Ph.D., she pursued studies in molecular biology and biotechnology, refining her expertise in cellular neuroscience. Throughout her education, she collaborated on interdisciplinary projects, integrating neurophysiology with pharmacological advancements. Her postdoctoral research extended into translational neuroscience, bridging laboratory findings with clinical applications. Aynurā€™s academic foundation laid the groundwork for her extensive research on cognitive function, stem cell therapy, and the gut-brain axis.

Experience šŸ‘Øā€šŸ«

With over a decade of experience, Aynur MĆ¼dĆ¼roğlu Kırmızıbekmez has been an Assistant Professor at Ä°stanbul Nişantaşı University since 2014. She has led multiple national and international neuroscience projects, including TƜSEB-approved research on Parkinsonā€™s and Alzheimerā€™s diseases. Aynur has played a pivotal role in developing functional foods aimed at cognitive enhancement and has secured patents for novel bioactive compounds. She actively collaborates with industry and academia, integrating neuroscience with biotechnology. Her teaching portfolio includes Neurology, Cognitive Neurophysiology, and Industrial Biotechnology. She has also mentored numerous graduate students in neuropharmacology and neurodegenerative research.

Research Interests šŸ”¬

Aynur MĆ¼dĆ¼roğlu Kırmızıbekmezā€™s research focuses on neurodegenerative diseases, neuroprotection, and the gut-brain axis. She explores innovative therapies for Alzheimerā€™s, Parkinsonā€™s, and autism, with a strong emphasis on stem cell applications. Her work investigates the neuroprotective potential of bioactive compounds and functional foods, aiming to enhance cognitive function. She has pioneered research on the microbiota-brain relationship, particularly the role of prebiotics in neurodegeneration. Aynurā€™s projects also include SNP-based qPCR diagnostic tools for Alzheimerā€™s risk assessment. Through interdisciplinary collaborations, she integrates neuroscience with biotechnology, advancing the understanding of cognitive disorders and potential therapeutic interventions.

Awards & Recognitions šŸ…

Aynur MĆ¼dĆ¼roğlu Kırmızıbekmez has received multiple awards for her contributions to neuroscience, including national research grants and innovation awards for her work on functional foods for neuroprotection. She was honored by TƜSEB for her groundbreaking research in stem cell therapy for Parkinsonā€™s disease. Her patented functional chocolate enriched with bioactive compounds received recognition for its cognitive benefits. Aynur has also been awarded project grants from TƜBÄ°TAK for her research on neurodegeneration. She has been invited as a keynote speaker at international neuroscience conferences and has been recognized for her contributions to cognitive science.

Publications šŸ“š

  • Attila Altunel, Aynur Muduroglu-Kirmizibekmez, Alparslan Onder, Ozlem Altunel, Ali
    Sever, Ihsan Kara, Efficacy of ACTH therapy in children with Landau-Kleffner Syndrome
    and Autism Spectrum Disorder: A retrospective analysis, Epilepsy & Behavior,Vol
    165,2025,110308, https://doi.org/10.1016/j.yebeh.2025.11030
  • Muduroglu-Kirmizibekmez A, Cati C, Onder A, Aydin S, Kara I. Investigation of the acute
    impact of rosemary consumption on brain activity in healthy volunteers. Nutr
    Neurosci. 2024 Jul 6:1-12. doi: 10.1080/1028415X.2024.2370729. Epub ahead of print.
    PMID: 38970803.
  • Biliz Y, Hasdemir B, Başpınar KĆ¼Ć§Ć¼k H, Zaim M, ŞentĆ¼rk AM, MĆ¼dĆ¼roğlu Kırmızıbekmez
    A, Kara Ä°. Novel N-Acyl Hydrazone Compounds as Promising Anticancer Agents:
    Synthesis and Molecular Docking Studies. ACS Omega. 2023 May 20;8(22):20073-
    20084. doi: 10.1021/acsomega.3c02361. PMID: 37305237; PMCID: PMC10249086.
  • Aydin S, Erƶzden AA, Tavşanlı N, MĆ¼dĆ¼roğlu A, Ƈalışkan M, Kara Ä°. Anthocyanin
    Addition to Kefir: Metagenomic Analysis of Microbial Community Structure. Curr
    Microbiol. 2022 Sep 20;79(11):327. doi: 10.1007/s00284-022-03017-x. PMID:
    36125585
  • Altunel Atilla, MĆ¼dĆ¼roğlu Kirmizibekmez Aynur, Altunel Emine Ɩzlem (2022).
    Hypsarrhythmia Paroxysm Intensities that Initiate and Render Physical & Mental
    Retardation Irreversible in West Syndrome. International Journal of Neuroscience,
    DOI: 10.1080/00207454.2022.2078208 (Publication No: 7685958)

Jeevitha Gowda R | Cognitive impairment | Best Researcher Award

Published on by Cognitive Scientist Awards

Ms. Jeevitha Gowda R | Cognitive impairment | Best Researcher Award

Assistant Professor, Alliance University, United Kingdom

šŸ§  Dr. Jeevitha Gowda R is a dedicated research scholar specializing in cognitive neuroscience and public health, with a strong focus on dementia prevention. She has expertise in developing cognitive screening tools, conducting neuropsychological assessments, and designing neuroscience-based interventions to enhance brain health. Currently serving as a Guest Faculty and Research Associate, she is passionate about bridging research with real-world applications. With proficiency in EEG, ERP, and data analysis, her work emphasizes cognitive aging, behavioral psychology, and mental well-being. Her research contributions include multiple conference presentations, publications, and cognitive training programs. She has received prestigious recognitions, including Best Paper Awards and research fellowships. Her commitment extends to community mental health programs, where she collaborates with NGOs and research institutions. Through her work, she aims to advance cognitive neuroscience and improve public health outcomes. šŸ“ššŸ”¬

Profile

Education šŸŽ“

šŸŽ“ Dr. Jeevitha Gowda R holds a Ph.D. in Cognitive Neuroscience and Public Health from Ramaiah University of Applied Sciences, Bengaluru (Thesis Submitted), focusing on developing cognitive tools for early dementia detection in primary healthcare settings. She earned a Masterā€™s in Cognitive Neuroscience from JSS Academy of Higher Education, Mysuru (2018), ranking among the top 3 students, with coursework in neural cognition, psychological assessment, and clinical interventions. Her dissertation explored mental fatigue due to sleep deprivation using EEG and ERP. She completed her Bachelorā€™s in Life Sciences from JSS College for Women, Mysuru (2016), excelling in biochemistry, microbiology, and environmental psychology. Additionally, she trained at the Defence Institute of Psychological Studies (DRDO) and Narayana Health, Bengaluru, gaining hands-on experience in EEG, neuropsychological assessments, and cognitive therapy. Her interdisciplinary education combines neuroscience, psychology, and public health, preparing her for impactful research and innovation in brain health. šŸ§ šŸ“–

Experience šŸ‘Øā€šŸ«

šŸ’¼ Dr. Jeevitha Gowda R has extensive experience as a Research Associate at the Centre for Integrative Health and Well-Being (2020ā€“Present), where she develops neuropsychological intervention tools and conducts cognitive behavioral therapy (CBT) programs. She also serves as a Senior Research Associate at Brighter Minds, focusing on cognitive enhancement and neuroscience-based training programs. As a Guest Lecturer at Ramaiah University of Applied Sciences (2021ā€“Present), she teaches biostatistics, neurophysiology, and psychology. Her past clinical internships at DRDO and Narayana Health provided her with hands-on expertise in EEG, ERP, and neuropsychological assessments. She has conducted research on cognitive impairment, dementia screening, and sleep deprivationā€™s effects on cognition. Additionally, she has authored 50+ neuroscience articles, presented at international conferences, and collaborated with NGOs for mental health awareness. Her diverse experience integrates academic, clinical, and research-based expertise to advance cognitive neuroscience and public health. šŸ„šŸ“Š

Research Interests šŸ”¬

šŸ”¬ Dr. Jeevitha Gowda R’s research bridges cognitive neuroscience, psychology, and public health, focusing on early dementia detection, cognitive aging, and neuropsychological interventions. She specializes in developing culturally relevant cognitive screening tools for primary healthcare, improving accessibility to dementia diagnostics. Her work explores neuropsychological assessments, EEG-based cognitive analysis, and behavioral interventions for enhancing mental well-being. She has conducted studies on sleep deprivation, cognitive impairment, and neurofeedback therapy. She collaborates with institutions like DRDO, Narayana Health, and Brighter Minds to implement neuroscience-driven programs. Her research extends to the psychological well-being of dementia caregivers, neurocognitive training for brain health, and integrating technology into mental health solutions. Through interdisciplinary studies and global research collaborations, she aims to advance early dementia detection methods and improve cognitive health strategies. Her work contributes to policy-making, clinical psychology, and public health initiatives. šŸ„šŸ“Š

Awards & Recognitions šŸ…

šŸ† Dr. Jeevitha Gowda R has received multiple accolades for her contributions to cognitive neuroscience and public health research. She won the Best Paper Award at the Epidemiology Foundation of India Conference (2023, Goa) for her groundbreaking work on dementia screening. Her research paper on cognitive tool validation earned a Special Mention at the International Dementia Conference (DEMCON-2024, IISC Bangalore). During her masterā€™s, she ranked among the top 3 dissertations at JSS Academy of Higher Education. She was awarded the Senior Research Fellowship (SRF) by Ramaiah University of Applied Sciences (2022ā€“2024) for her Ph.D. research. She has also secured research grants for projects on dementia detection and cognitive enhancement. Recognized for her impactful contributions, she collaborates with prestigious institutions, including DRDO and Narayana Health, to advance neuropsychological research. Her work continues to shape innovations in mental health and aging. šŸŽ–ļøšŸ§ 

Publications šŸ“š

  • Jeevitha Gowda R, Anish Mehta, Krishnamurthy Jayanna. (2025).
    Dementia: A Public Health Challenge in India. South Eastern European
    Journal of Public Health, 29ā€“43. Retrieved from
    hps://www.seejph.com/index.php/seejph/article/view/3295 (Scopus)

  • Jeevitha Gowda R. The Impact of Cultural Beliefs and Stigma on
    Dementia Care and Diagnosis: A Scoping Review, 25 November 2024,
    PREPRINT (Version 1) available at Research Square
    hps://doi.org/10.21203/rs.3.rs-5519592/v1
  • Jeevitha Ramesh, Parimala Guruprasad (2024) Factors Affecting the
    Psychological Well-Being of Caregivers of Dementia Patients: A
    Thematic Review. Journal of Neurology Research Reviews & Reports.
    SRC/JNRRR-260
  • Development and Validation of Cognitive Screening Tools for
    Dementia Detection in Primary Care Seings: An Exploratory Pilot
    Study ā€“ Under review at International Journal of Geriatric Psychiatry.
    (Corresponding Author)
  • Burden of Cognitive Impairment Including Dementia, and Associated
    Risk Factors Among the Rural Population of South Karnataka, India ā€“
    Under review at Journal of Public Health Research. (Corresponding
    Author)
  • Impact of Training Module on Lifestyle and Healthy Behaviours: An
    Exploratory Pilot in India ā€“ Under review at Journal Explore.
    (Co-Author)

Gerardo Fernandez | Eye tracking | Excellence in Innovation

Published on by Cognitive Scientist Awards

Dr. Gerardo Fernandez | Eye tracking | Excellence in Innovation

Gerardo Abel FernĆ”ndez šŸ‡¦šŸ‡·, born on October 29, 1976, in BahĆ­a Blanca, Argentina, is a researcher specializing in neuroscience and cognitive science šŸ§ . He is a professor and adjunct researcher at CONICET, focusing on eye movement-based biomarkers for neurodegenerative diseases šŸ‘€. His work integrates philosophy, cognitive psychology, and technology to advance Alzheimerā€™s diagnosis šŸ„.

Profile

Education šŸŽ“

šŸŽ“ Gerardo Abel FernĆ”ndez obtained a degree in Philosophy (2003) from Universidad Nacional del Sur (UNS), Argentina, with a specialization in Logic and Epistemology. He later pursued a PhD in Philosophy (2011) at UNS, with his thesis titled “Dynamic word processing during reading: Mental strategies driving visual exploration”, earning a perfect 10/10 with special mention. His academic journey includes postdoctoral research as a fellow at AGENCIA (ANPCYT) and the DAAD Max Planck Institute in Berlin. His educational background bridges philosophy, neuroscience, and cognitive psychology, forming a solid foundation for his pioneering research in eye movement analysis and Alzheimerā€™s biomarkers. His expertise in cognitive science and technological innovation has led to the development of diagnostic tools for early neurodegenerative disease detection. šŸ“ššŸ”šŸ§ 

Experience šŸ‘Øā€šŸ«

šŸ’¼ Dr. Gerardo Abel FernĆ”ndez has extensive experience in neuroscience research and technological innovation. He served as a Professor of Audiovisual Language at UNS (2011ā€“2013) and is currently an Adjunct Researcher at CONICET, focusing on non-endemic degenerative pathologies. He has worked as a Visiting Scholar at Heriot-Watt University and Strathclyde University (UK), contributing to the development of eye-tracking biomarkers for Alzheimerā€™s disease. Dr. FernĆ”ndez is also a scientific reviewer for prestigious journals like PlosOne, Journal of Alzheimerā€™s Disease, and Neuropsychologia. As CTO of Viewmind, he leads biocognitive and functional performance measurement innovations. He has patented cognitive evaluation methods and received grants from institutions like ANPCYT and DAAD. His interdisciplinary expertise spans cognitive neuroscience, machine learning applications in diagnostics, and technological development for neurodegenerative disease assessment. šŸ…šŸ”¬šŸ‘ļø

Research Interests šŸ”¬

šŸ”¬ Dr. Gerardo Abel FernĆ”ndez specializes in cognitive neuroscience, neurodegenerative disease biomarkers, and eye-tracking technology. His research focuses on early Alzheimerā€™s detection through oculomotor behavior analysis. He has developed innovative methods to study visual exploration, reading difficulties, and memory impairments in neurodegenerative conditions. His work integrates machine learning and artificial intelligence for cognitive assessment tools. As a Visiting Scholar in the UK, he contributed to developing biomarkers for Alzheimerā€™s disease. His patented eye-tracking system has clinical applications in detecting mild cognitive impairment and Alzheimerā€™s disease. He has published extensively in peer-reviewed journals, exploring predictive eye movement models and their correlation with cognitive decline. His cutting-edge research bridges philosophy, neuroscience, and technology, offering non-invasive diagnostic solutions for early-stage neurodegeneration. His ultimate goal is to revolutionize cognitive healthcare through technological innovation. šŸ§ šŸ‘ļøšŸ“Š

Awards & Recognitions šŸ…

šŸ† Dr. Gerardo Abel FernĆ”ndez has received numerous awards for his contributions to neuroscience, cognitive evaluation, and Alzheimerā€™s diagnostics. His eye-tracking research for Alzheimerā€™s detection earned the Dr. JosĆ© Borda Clinical Psychiatry Prize at the 22nd International Congress of Psychiatry. He won the Novartis Innovation Award for his work on measuring cognitive performance in health and disease. As CTO of Viewmind, his team received international recognition, including the Fit4Start Luxembourg Award for health applications and the Medica Innovation Prize in DĆ¼sseldorf. His research and patented cognitive evaluation equipment have been acknowledged by ANMAT (Argentinaā€™s National Administration of Drugs, Foods, and Medical Technology) and INPI (Argentinaā€™s National Patent Office). Dr. FernĆ”ndez’s groundbreaking innovations in neurocognitive assessments have positioned him as a leading figure in technological advancements for early Alzheimerā€™s detection. šŸ…šŸ§ šŸ”¬

Publications šŸ“š

  • Oculomotor behaviors and integrative memory functions in the alzheimer’s clinical syndrome

    Journal of Alzheimer’s Disease
    2021 |Ā Journal article
    DOI:Ā 10.3233/JAD-201189

  • A non-invasive tool for attention-deficit disorder analysis based on gaze tracks.

    ACM International Conference Proceeding Series
    2019 |Ā Conference paper
    DOI:Ā 10.1145/3309772.3309777

  • Microsaccadic behavior when developing a complex dynamical activity

    Journal of Integrative Neuroscience
    2018 |Ā Journal article
    DOI:Ā 10.3233/JIN-170057

    EID:

    2-s2.0-85053731401